Talaris Therapeutics

Scott Requadt, CEO 

Louisville, KY 

(NASDAQ: TALS) 

Virtual Presentation 

Talaris Therapeutics is a late clinical-stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX. 

www.talaristx.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions